HB 1034 Summary

• Adds five drugs to Schedule I (no legitimate medical use, high potency, great potential for harm): isotonitazene, flualprazolam, flubromazepam, flubromazolam, and clonazolam.

• Revises the chemical name of thiafentanil in Schedule II from the previous designation to "methyl 4-(2-methoxy-N-phenylacetamido)-1-(2-(thiophen-2-yl)ethyl)piperidine-4-carboxylate."

• Adds brexanolone and solriamfetol to Schedule IV as controlled substances based on recent Federal Food and Drug Administration approval for medical use.

• Effective July 1, 2021.